Developing a quick test for monitoring HIV viral load to aid in new cure strategies

Point-of-care viral load monitoring to support large-scale clinical testing of new HIV cure strategies

NIH-funded research Fluid Discovery INC · NIH-10822970

This study is working on a new, easy-to-use test that can quickly and accurately check the amount of HIV in your blood while you're on treatment, helping doctors keep track of your health and spot any changes that might need attention.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionFluid Discovery INC NIH-funded
Lab location1 site (San Francisco, UNITED STATES)
Project IDNIH-10822970 on NIH RePORTER

What this research studies

This research focuses on creating a point-of-care test that can accurately measure HIV viral load in patients undergoing antiretroviral therapy (ART). The goal is to develop a cost-effective and sensitive method that can quickly detect changes in viral load, helping to identify patients who may experience a rebound in the virus after stopping ART. By using a technique called digital loop-mediated isothermal amplification (dLAMP), the test aims to provide precise measurements from raw blood samples, facilitating large-scale clinical trials for new HIV cure strategies. This innovative approach could significantly improve patient monitoring and treatment outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living with HIV who are currently on antiretroviral therapy and may be eligible for clinical trials of new cure strategies.

Not a fit: Patients who are not currently on antiretroviral therapy or those who do not have HIV may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective monitoring of HIV patients and support the development of a potential cure for HIV.

How similar studies have performed: Other research has shown promise in developing point-of-care tests for viral load monitoring, indicating that this approach has potential for success.

Where this research is happening

San Francisco, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency SyndromeAcquired Immunodeficiency Syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.